DYRK1A and Brachycephaly: We hypothesise that increased dosage of Dyrk1a leading to reduced proliferation of NC-derived cells results in smaller facial and frontal bones, and aberrant fusion of the synchondroses, which together lead to brachycephaly and midfacial hypoplasia.